Clinical Trials on Lower Urinary Tract Symptoms

Total 92565 results

Maastricht University Medical Center

Unknown

Brain Areas Involved in Bladder Filling and Contraction

Urinary Bladder, Overactive

Netherlands
Ferring Pharmaceuticals

Completed

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) (PALAT)

Primary Nocturnal Enuresis

France
Winthrop University Hospital

Completed

Study of Idiopathic Edema

Idiopathic Edema Nocturia

United States
Vantia Ltd

Completed

Efficacy Study of VA106483 in Males With Nocturia.

Nocturia

United States
University of California, San Francisco
National Institute on Aging (NIA)

Completed

Controlling Urgency Through Relaxation Exercises (CURE)

Overactive Bladder | Urgency Incontinence | Urgency Urinary Symptoms

United States
Astellas Pharma Inc

Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (ARIES)

Urinary Bladder, Overactive

United States, Canada
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Astellas Pharma Inc

Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (TAURUS)

Urinary Bladder, Overactive

Canada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
Astellas Pharma Inc

Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (CAPRICORN)

Urinary Bladder, Overactive

United States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
Astellas Pharma Europe B.V.

Completed

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder (Blossom)

Urinary Bladder, Overactive

Belgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
Medway NHS Foundation Trust

Completed

A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder

Urogynaecology

United Kingdom
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Completed

Behavioural Therapy Program for Female Overactive Bladder

Urinary Bladder, Overactive

Turkey
Bayer

Completed

A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function

Overactive Bladder | Detrusor Overactivity

Spain, Belgium, Canada, Netherlands, Switzerland, Russian Federation, Germany, Israel, Hungary, Portugal, France, Poland, Czech Republic
National Taiwan University Hospital

Completed

Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

Antimuscarinic Drug

Taiwan
Pfizer

Completed

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

Urinary Bladder, Overactive

Australia, France, Colombia, Germany, Canada, Finland, Slovakia, Spain, Switzerland, Italy, Chile, Greece, Latvia, Norway, Poland, United Kingdom
Astellas Pharma Inc

Completed

A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

Urinary Bladder, Overactive

China
Istituto Clinico Humanitas

Recruiting

Effects of Action Observation Training (AOT) in the Achievement of Urinary Continence in Men After Robot-assisted Laparoscopic Prostatectomy (RALP)

Urinary Incontinence

Italy
University of Sao Paulo

Recruiting

Biofeedback Versus Vaginal Palpation to Teach a Voluntary Pelvic Floor Muscle Contraction

Urinary Incontinence

Brazil
Essity Hygiene and Health AB
Smerud Medical Research Germany Ltd

Completed

Evaluation of Urine Leakage of New Absorbing Incontinence Products in a Home Care Environment

Urinary Incontinence

Germany
Yale University

Completed

Voiding Diary Video

Urinary Incontinence

United States
Essity Hygiene and Health AB

Completed

Detectability of the Bladder With an Early Prototype of the Bladder Sensor

Urinary Incontinence

Netherlands
Ambu A/S
QserveCRO

Completed

Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy

Lower Urinary Tract Symptoms | Bladder Disease | Cystoscope

Netherlands, Denmark
Glasgow Caledonian University
National Institute for Health Research, United Kingdom

Unknown

ELECtric Tibial Nerve Stimulation to Reduce Incontinence in Care Homes (ELECTRIC)

Urinary Incontinence

United Kingdom
Southwest Regional Wound Care Center

Completed

A Prospective Analysis of Biofilm in Urinary Catheters Study

Urinary Incontinence

United States
G.R. Dome Medical Ltd.

Unknown

Feasibility of the UriCap-F for Urine Collection in Hospitalized Women

Urinary Incontinence
G.R. Dome Medical Ltd.

Unknown

Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients

Urinary Incontinence
University of British Columbia
British Columbia Cancer Agency

Unknown

Gynecological Pelvic Floor Muscle Training

Urinary Incontinence

Canada
Kanuni Sultan Suleyman Training and Research Hospital

Unknown

Impact of Urethral Mobility on the Success of Sling Operations

Urinary Incontinence

Turkey
Coloplast A/S

Completed

Bladder Scan of Residual Urine With New Catheter

Urinary Incontinence

Germany
Copenhagen University Hospital at Herlev

Withdrawn

Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Treatment of Incontinence (TMNS)

Urinary Incontinence

United States, Denmark
Eli Lilly and Company

Completed

Urge Incontinence Bladder Overactivity Study

Urinary Incontinence

United States, Australia, Canada
Loyola University
Kimberly-Clark Corporation

Completed

Investigation of the Effect of the Female Urinary Microbiome on Incontinence (FUM)

Overactive Bladder | Nocturia | Incontinence

United States
Loma Linda University

Completed

"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"

Overactive Bladder | Menopause | Caffeine

United States
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets

Overactive Bladder

Japan
Astellas Pharma Inc

Completed

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

Urinary Bladder, Overactive

China, Taiwan, India, Korea, Republic of
Allergan

Completed

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Overactive Bladder | Pharmacokinetics | Elderly

United States
Astellas Pharma Europe Ltd.

Terminated

An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics

Overactive Bladder | Healthy Subjects

Netherlands
Allergan

Completed

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

Urinary Bladder, Overactive

France, United States, Netherlands
Boston Scientific Corporation

Completed

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Overactive Bladder

United States
Pfizer

Completed

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. (SOFIA)

Urinary Bladder, Overactive

Portugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
Istanbul Medeniyet University

Completed

Turkish Validation and Reliability of LURN SI-29 Questionnaire in Patients With Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Urinary Incontinence

Turkey
Hollister Incorporated

Completed

Consumer Evaluation of Intermittent Catheter Product Modifications

Urinary Incontinence

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Urinary Incontinence

China
Pfizer's Upjohn has merged with Mylan to form Viatris...
Pfizer

Completed

Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

Urinary Incontinence
Astellas Pharma Inc

Completed

A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

Urinary Incontinence

United States, Canada
University of Rochester

Completed

Assessment of Two Postoperative Techniques Used to Predict Voiding Efficiency After Gynecologic Surgery

Urinary Incontinence

United States
Karolinska Institutet

Completed

Polyacrylamide Injection in Patients Ineligible for Surgery

Urinary Incontinence
Maastricht University Medical Center
Scientific Foundation Urology Maastricht

Completed

Screening Method in Sacral Neuromodulation

Overactive Bladder | Urinary Retention

Netherlands
Boehringer Ingelheim

Completed

Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms

Prostatic Hyperplasia
Binding Sciences Limited
Buckinghamshire Healthcare NHS Trust

Not yet recruiting

Evaluation Trial of Handheld Urinal for Adult Use

Urinary Incontinence

United Kingdom

Clinical Trials on Lower Urinary Tract Symptoms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations